NCT02212769View on ClinicalTrials.gov

the Pharmacokinetic Profiles of Losartan With DW1029M

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

February 28, 2015

Conditions
Healthy
Interventions
DRUG

Losartan 50mg

Losartan 50mg once daily for 7 days

DRUG

DW1029M 1200mg and Losartan 50mg

Losartan 50mg 1 Tablet once daily and DW1029M 300mg 2 Tablets b.i.d. for 7days

Trial Locations (1)

561-712

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Dong Wha Pharmaceutical Co. Ltd.

INDUSTRY